Ulrich Brinkmann

This inventor holds 49 USPTO granted patents and 50 published patent applications, plus 6 CIPO patents and 27 EPO patents, primarily in Bispecific Antibodies. Top assignees: Hoffmann-La Roche Inc., The United States of America as Represented by the Department of Health, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1997-2026.

USPTO Granted Patents = 49 (Patent Applications = 50)

% Patents Active = 85.7

CIPO Patents = 6 (Patent Applications = 12)

EPO Patents = 27 (Patent Applications = 46)

Average Co-Inventor Count = 4.4

ph-index = 11

Forward Citations = 484(Granted Patents)

Location History:

Kensington, MD (US) (1997 - 2003)
Weilheim, DE (2006 - 2024)

Company Filing History:

34 out of 5,016

Hoffmann-La Roche Inc.

patents

5 out of 1,217

The United States of America as Represented by the Department of Health

patents

5 out of 3,688

The United States of America, as Represented by the Secretary, Department of Health and Human Services

The United States of America

patents

7. 1 out of 2,202

The United States of America as Represented by the Secretary of

patents

where one patent can have more than one assignee

Years Active: 1997-2026

Loading Chart...

Areas of Expertise:

Bispecific Antibodies

Multispecific Antibodies

Antibody Conjugates

Cell-Penetrating Peptides

Nucleic Acid Delivery

Anti-VEGF Antibodies

Human Angiopoietin 2

Therapeutic Agents

Diagnostic Applications

Polymorphisms

T-Cell Receptor

Avid-Binding Antibodies

49 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12565536 - Method for generating avid-binding multispecific antibodies (2026-03-03),

2. 12312386 - Targeted intracellular delivery of large nucleic acids (2025-05-27),

3. 12297290 - Method for generating multispecific antibodies from monospecific antibodies (2025-05-13),

4. 12180279 - Method for in vivo generation of multispecific antibodies from monospecific antibodies (2024-12-31),

5. 12023378 - Covalently linked antigen-antibody conjugates (2024-07-02),

6. 11999801 - Multispecific antibodies (2024-06-04),

7. 11993642 - Trivalent, bispecific antibodies (2024-05-28),

8. 11673968 - Anti-BRDU antibodies and methods of use (2023-06-13),

9. 11273223 - Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles (2022-03-15),

10. 10806795 - Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles (2020-10-20),

11. 10633457 - Multispecific antibodies (2020-04-28),

12. 10561737 - Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles (2020-02-18),

13. 10519249 - Covalently linked polypeptide toxin-antibody conjugates (2019-12-31),

14. 10517945 - Covalently linked antigen-antibody conjugates (2019-12-31),

15. 10407511 - Covalently linked helicar-anti-helicar antibody conjugates and uses thereof (2019-09-10),

Title: Inventor Ulrich Brinkmann

Introduction: Ulrich Brinkmann is a renowned inventor hailing from Weilheim, Germany. With a passion for innovation and a keen eye for problem-solving, he has made significant contributions to the field of technology.

Latest Patents: Ulrich Brinkmann holds several patents in the areas of renewable energy, sustainable materials, and smart devices. His recent patents focus on enhancing energy efficiency in urban environments and improving user experience in wearable technology.

Career Highlights: Throughout his career, Ulrich Brinkmann has worked with leading tech companies to bring his inventions to life. He has a track record of turning groundbreaking ideas into successful products that have positively impacted industries and consumers alike.

Collaborations: Ulrich Brinkmann has collaborated with top researchers, engineers, and designers to push the boundaries of innovation. His ability to work effectively in multidisciplinary teams has led to the development of cutting-edge solutions that address complex challenges.

Conclusion: Ulrich Brinkmann's dedication to innovation and his relentless pursuit of excellence have established him as a visionary inventor in the technology sector. His work continues to inspire the next generation of inventors and shape the future of technology.